For: | Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol 2005; 11(38): 6009-6013 [PMID: 16273615 DOI: 10.3748/wjg.v11.i38.6009] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i38/6009.htm |
Number | Citing Articles |
1 |
Mohammad Sholeh, Farajolah Maleki, Marcela Krutova, Shirin Bavari, Rezvan Golmoradi, Nourkhoda Sadeghifard, Taghi Amiriani, Ebrahim Kouhsari. The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta‐analysis. Helicobacter 2020; 25(5) doi: 10.1111/hel.12730
|
2 |
Mohammad Reza Esmaeili-Dooki, Hossein Shirdel, Mahmood Hajiahmadi. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Iranian Journal of Pediatrics 2015; 25(6) doi: 10.5812/ijp.2360
|
3 |
Gita Eslami, Soudabeh Taheri, Neda Baseri, Seyed Ali Montazeri, Abdolvahid Shakeri, Roghayeh Samadi, Hosein Dabiri, Zahra Zahirnia, Azanollah Azargashb. Prevalence of Helicobacter pylori and Determination of Antibiotic Resistance in Patients with Gastritis Referred to Shahid Beheshti University of Medical Sciences Hospitals in Tehran Between 2010 and 2011. Archives of Clinical Infectious Diseases 2012; 8(1): 18 doi: 10.5812/archcid.16031
|
4 |
Mahnaz Shahabimehr, Masoud Alebouyeh, Nastaran Farzi, Arash Mahboubi, Reza Taslimi, Mohammad Reza Zali. Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran. Archives of Clinical Infectious Diseases 2016; 11(2) doi: 10.5812/archcid.34478
|
5 |
Shohreh Maleknejad, Ali Mojtahedi, Afshin Safaei-Asl, Zeinab Taghavi, Ehsan Kazemnejad. Primary Antibiotic Resistance to Helicobacter pylori Strains Isolated From Children in Northern Iran: A Single Center Study. Iranian Journal of Pediatrics 2015; 25(6) doi: 10.5812/ijp.2661
|
6 |
Shahrbanoo Keshavarz Azizi Raftar, Rezvan Moniri, Mahmood Saffari, Mohsen Razavi Zadeh, Abbas Arj, Seyed Gholam Abbas Mousavi, Hamed Mirzaei Ghazi Kalayeh, Kamran Dastehgoli. The Helicobacter pylori Resistance Rate to Clarithromycin in Iran. Microbial Drug Resistance 2015; 21(1): 69 doi: 10.1089/mdr.2014.0104
|
7 |
Krisztina Hagymási, Zsolt Tulassay. The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance. Orvosi Hetilap 2008; 149(43): 2029 doi: 10.1556/oh.2008.28460
|
8 |
Ali Gholamrezanezhad, Shadi Kolahdoozan, Sahar Mirpour. Comments on “The relation between Helicobacter pylori infection and cardiac syndrome X: A preliminary study", Assadi M, et al.. International Journal of Cardiology 2010; 141(1): 114 doi: 10.1016/j.ijcard.2008.11.062
|
9 |
Maria Pina Dore, Hong Lu, David Y Graham. Role of bismuth in improvingHelicobacter pylorieradication with triple therapy. Gut 2016; 65(5): 870 doi: 10.1136/gutjnl-2015-311019
|
10 |
Samin Alihosseini, Reza Ghotaslou, Fatemah Sadeghpour Heravi, Zainab Ahmadian, Hamed Ebrahimzadeh Leylabadlo. Management of antibiotic-resistantHelicobacter pyloriinfection: current perspective in Iran. Journal of Chemotherapy 2020; 32(6): 273 doi: 10.1080/1120009X.2020.1790889
|
11 |
E Ahmadzadeh, H Zarkesh-Esfahani, R Roghanian, F Navab Akbar. Comparison of Helicobacter pylori and Escherichia coli in induction of TNF-α mRNA from human peripheral blood mononuclear cells. Indian Journal of Medical Microbiology 2010; 28(3): 233 doi: 10.4103/0255-0857.66482
|
12 |
Afsaneh Sikarchi, Leila Fozouni. Inhibitory Effect of Probiotic Bacteria Isolated from Camel Milk on Clinical Strains of Drug-Resistant Helicobacter pylori. Medical Laboratory Journal 2018; 12(2): 20 doi: 10.29252/mlj.12.2.20
|
13 |
Hamid Abdollahi, Mostafa shokoohi, Mohammad Savari. The Prevalence of <italic>Helicobacter pylori</italic> <italic>babA2, iceA1 </italic> and <italic>iceA2 </italic> Genes and Their Association with Clinical Outcomes in Patients with Chronic Gastritis, Ulcerative Diseases and Non-Ulcer Dyspepsia in South East of Iran. Jundishapur Journal of Microbiology 2013; 6(4) doi: 10.5812/jjm.4739
|
14 |
You‐hua Wang, Zhen Li, Le Wang, Li‐ya Zhu‐ge, Ru‐lin Zhao, Shuang Wu, Ya Wang, Ying An, Yong Xie. A systematic review and meta‐analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. Helicobacter 2018; 23(2) doi: 10.1111/hel.12467
|
15 |
Amirarsalan Serajian. PCR-RFLP Detection of Point Mutations in 23sr RNA Gene Responsible for Clarithromycin Resistance in Helicobacter pylori Isolates of Ahvaz, Iran. International Journal of Molecular Biology 2017; 2(5) doi: 10.15406/ijmboa.2017.02.00038
|
16 |
Nimish Vakil, Francis Megraud. Eradication Therapy for Helicobacter pylori. Gastroenterology 2007; 133(3): 985 doi: 10.1053/j.gastro.2007.07.008
|
17 |
Amin Talebi Bezmin Abadi, Tarang Taghvaei, Ashraf Mohabbati Mobarez, Beth M. Carpenter, D. Scott Merrell. Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. The Journal of Microbiology 2011; 49(6): 987 doi: 10.1007/s12275-011-1170-6
|
18 |
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. Infection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
|
19 |
Maryam Shirani, Reza Pakzad, Mohammad Hossein Haddadi, Sousan Akrami, Arezoo Asadi, Hossein Kazemian, Melika Moradi, Vahab Hassan Kaviar, Abolfazl Rafati Zomorodi, Saeed Khoshnood, Mahnaz Shafieian, Ronia Tavasolian, Mohsen Heidary, Morteza Saki. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08504-5
|
20 |
Hafez Fakheri, Zohreh Bari, Mohsen Aarabi, Reza Malekzadeh. <italic>Helicobacter pylori</italic> eradication in West Asia: A review. World Journal of Gastroenterology 2014; 20(30): 10355-10367 doi: 10.3748/wjg.v20.i30.10355
|
21 |
Sh. Rezaei, A. Talebi Bezmin Abadi, A. Mohabatti Mobarez. Metronidazole-resistant Helicobacter pylori isolates without rdxA mutations obtained from Iranian dyspeptic patients. New Microbes and New Infections 2020; 34: 100636 doi: 10.1016/j.nmni.2019.100636
|
22 |
Majid Assadi, Mohsen Saghari, Iraj Nabipour, Mohammad Reza Pourbehi, Mohammad Eftekhari, Abdolali Ebrahimi, Moloud Abbaszadeh, Mozhdeh Nasiri, Mozhgan Nazarahari, Sakineh Assadi. Reply to comments on “The relation between Helicobacter pylori infection and cardiac syndrome X: A preliminary study”. International Journal of Cardiology 2010; 141(1): 115 doi: 10.1016/j.ijcard.2008.11.099
|
23 |
Farzad Khademi, Amir Hossein Sahebkar, Hamid Vaez, Mohsen Arzanlou, Hadi Peeridogaheh. Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2017; 10: 171 doi: 10.1016/j.jgar.2017.05.021
|
24 |
Mojdeh Hakemi Vala, Shirin Eyvazi, Hossein Goudarzi, Hamid Reza Sarie, Mehrdad Gholami. Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods. Jundishapur Journal of Microbiology 2016; 9(5) doi: 10.5812/jjm.29839
|
25 |
Leila Lormohammadi, Farhad Nikkhahi, Shahin Bolori, Ali Akbar Karami, Sepideh Hajian, Neda Rad, Amir Peymani, Rasoul Samimi. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, Iran. Gene Reports 2022; 26: 101494 doi: 10.1016/j.genrep.2022.101494
|
26 |
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
|
27 |
Seyed Mohammad Valizadeh Toosi, Sahar Feyzi, Arash Kazemi. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. The Korean Journal of Gastroenterology 2024; 83(4): 150 doi: 10.4166/kjg.2024.012
|
28 |
Mohammad Hassan Emami, Mohammad Mehdi Saberfiroozi, Abbas Arj, Ali Reza Taghavi, Kamran Bagheri-Lankarani, Najaf Dehbashi, Mohammad Reza Fattahi, Mahvash Alizadeh, Mohammad Javad Kaviani, Rahim Bahri-Najafi, Bita Geramizadeh, Abbas Esmaeili. Does delayed gastric emptying shorten the <italic>H pylori</italic> eradication period? A double blind clinical trial. World Journal of Gastroenterology 2006; 12(39): 6310-6315 doi: 10.3748/wjg.v12.i39.6310
|
29 |
Ali Baradaran Moghaddam, Nour Amirmozafari, Shahla Mansouri, Nastaran Farzi, Naser Ebrahimi-Daryani, Masoud Alebouyeh, Mohammad Reza Zali. Nitazoxanide and Doxycycline Sensitivity Among Metronidazole Resistant Helicobacter pylori Isolates from Patients with Gastritis. Archives of Clinical Infectious Diseases 2018; 13(1) doi: 10.5812/archcid.66693
|
30 |
Hafez Fakheri, Mehdi Saberi Firoozi, Zohreh Bari. Eradication of Helicobacter Pylori in Iran: A Review. Middle East Journal of Digestive Diseases 2017; 10(1): 5 doi: 10.15171/mejdd.2017.84
|
31 |
J. YAKOOB, W. JAFRI, Z. ABBAS, S. ABID, S. NAZ, R. KHAN, A. KHALID. Risk factors associated withHelicobacter pyloriinfection treatment failure in a high prevalence area. Epidemiology and Infection 2011; 139(4): 581 doi: 10.1017/S0950268810001226
|
32 |
Mandana Rafeey, Reza Ghotaslou, Solmaz Nikvash, Asghar Ashrafy Hafez. Primary resistance in Helicobacter pylori isolated in children from Iran. Journal of Infection and Chemotherapy 2007; 13(5): 291 doi: 10.1007/s10156-007-0543-6
|
33 |
Abdol Rahim Masjedizadeh, Eskandar Hajiani, Seyed Jalal Hashemi, Pezhman Alavinejad, Hasan Dalvand. Sequential Therapy vs Quadruple Therapy for
Helicobacter pylori Eradication in South West of Iran. Euroasian Journal of Hepato-Gastroenterology 2014; 4(2): 63 doi: 10.5005/jp-journals-10018-1103
|
34 |
Marjan Mohammadi, Bahareh Attaran, Reza Malekzadeh, David Y. Graham. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Digestive Diseases and Sciences 2017; 62(8): 1890 doi: 10.1007/s10620-017-4628-5
|
35 |
Shima Mahmoudi, Setareh Mamishi, Maryam Banar, Sepideh Keshavarz Valian, Abbas Bahador, Mehri Najafi, Fatemeh Farahmand, Babak Pourakbari. Antibiotic susceptibility of Helicobacter pylori strains isolated from Iranian children: High frequency of A2143G point mutation associated with clarithromycin resistance. Journal of Global Antimicrobial Resistance 2017; 10: 131 doi: 10.1016/j.jgar.2017.04.011
|
36 |
Morteza Milani, Reza Ghotaslou, Mohammad H. Somi, Mandana Rafeey, Morteza Milani, Reza Ghotaslou, Mohammad T. Akhi, Mohammad R. Nahaei, Alka Hasani, Yaeghob Sharifi, Reza Ghotaslou. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. Journal of Infection and Chemotherapy 2012; 18(6): 848 doi: 10.1007/s10156-012-0425-4
|
37 |
Sara Hamidi, Farzad Badmasti, Fatemah Sadeghpour Heravi, Mohammed Hossein Safapoor, Amir Mohammad Ali Tabrizi, Mohammad Ghorbani, Omid Azizi. Antibiotic resistance and clonal relatedness of Helicobacter pylori strains isolated from stomach biopsy specimens in northeast of Iran. Helicobacter 2020; 25(2) doi: 10.1111/hel.12684
|
38 |
Mohammad Minakari, Amir Hosein Davarpanah Jazi, Ahmad Shavakhi, Neda Moghareabed, Farinaz Fatahi. A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second‐Line Therapy in Patients With Helicobacter pylori Infection. Helicobacter 2010; 15(2): 154 doi: 10.1111/j.1523-5378.2009.00739.x
|
39 |
David Y. Graham, Sun-Young Lee. How to Effectively Use Bismuth Quadruple Therapy. Gastroenterology Clinics of North America 2015; 44(3): 537 doi: 10.1016/j.gtc.2015.05.003
|
40 |
Leila Manzouri, Farzaneh Zarei, Narjes Niazi, Moslem Sedaghattalab. Comparison of the Success Rate of Quadruple and Triple Antibiotic Therapy in Eradicating Helicobacter pylori Infection in Southwest of Iran: A Randomized Clinical Trial. International Journal of Infection 2017; 4(3) doi: 10.5812/iji.15610
|
41 |
Amin Talebi Bezmin Abadi, Ashraf M. Mobarez, Tarang Taghvaei, Lutz Wolfram. Antibiotic Resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 2010; 15(6): 505 doi: 10.1111/j.1523-5378.2010.00795.x
|
42 |
Hafez Fakheri, Zeinab Bakhshi, Zohreh Bari, Saman Alhooei. Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure. Middle East Journal of Digestive Diseases 2015; 8(1): 51 doi: 10.15171/mejdd.2016.07
|
43 |
Hassan Salmanroghani, Massoud Mirvakili, Mahmud Baghbanian, Roham Salmanroghani, Golshid Sanati, Pouria Yazdian, John Green. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial. PLOS ONE 2018; 13(6): e0197096 doi: 10.1371/journal.pone.0197096
|
44 |
Nasrin Mirzaei, Farkhondeh Poursina, Jamshid Faghri, Majid Talebi, Mohammad Reza Khataminezhad, Akbar Hasanzadeh, Hajieh Ghasemian Safaei. Prevalence of Resistance of Helicobacter pylori Strains to Selected Antibiotics in Isfahan, Iran. Jundishapur Journal of Microbiology 2013; 6(5) doi: 10.5812/jjm.6342
|